COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Recent Advances in Parkinsons Disease - 1st Edition - ISBN: 9780444536143, 9780444536242

Recent Advances in Parkinsons Disease, Volume 183

1st Edition

Part I: Basic Research

Serial Volume Editors: Anders Bjorklund Angela Cenci-Nilsson
Hardcover ISBN: 9780444536143
eBook ISBN: 9780444536242
Imprint: Elsevier
Published Date: 20th August 2010
Page Count: 332
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

Section I: Genetic and molecular mechanisms of neurodegeneration in PD


Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects

Thomas Gasser


The impact of genetic research on our understanding of Parkinson's Disease

Ted Dawson

Ian Martin, Valina L. Dawson


Unraveling the role of defective genes

Mark Cookson


What causes the death of dopaminergic neurons in Parkinson’s disease?

James Surmeier

Jaime N. Guzman, Javier Sanchez-Padilla and Joshua Goldberg


Intracellular Signaling Pathways In Dopamine Cell Death And Axonal Degeneration

Robert Burke


Control of mitochondrial integrity in Parkinson’s Disease

Serge Przedborski

Cristofol Vives-Bauza, Maja Tocilescu, Rosa L. A. deVries, Dana M. Alessi, Vernice Jackson-Lewis


Role of Post-Translational Modifications in Modulating the Structure, Function and Toxicity of α-synuclein: Implications for Parkinson’s Disease Pathogenesis and Therapies

Hilal Lashuel

Abid Oueslati, Margot Fournier

Section II: Cellular and system-level pathophysiology of the basal ganglia in PD


The role of dopamine in modulating the structure and function of striatal circuits

James Surmeier

Weixing Shen, Michelle Day, Tracy Gertler, Savio Chan, Xianyong Tian and Joshua L. Plotkin


Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson’s disease

Monica Di Luca

Paolo Calabresi


Adenosine-dopamine interactions

Micaela Morelli

Anna R Carta, Anil Kachroo, Michael A. Schwarzschild


Maladaptive plasticity in L-DOPA-induced dyskinesia

M. Angela Cenci

Christine Konradi


Effects of GPi and STN inactivation on physiological, motor, cognitive

and motivational processes in animal models of Parkinson's disease

Chistelle Baunez

Paolo Gubellini


Computational physiology of the basal ganglia in Parkinson’s disease

Hagai Bergman

Michal Rivlin-Etzion, Shlomo Elias, Gali Heimer


Neurocomputational models of motor and cognitive

deficits in Parkinson's Disease

Michael J. Frank

Thomas V. Wiecki


This first volume starts with an overview on current perspectives in genetic research and on the molecular mechanisms of neurodegeneration. This is followed by a selection of hot topics in pathophysiological research, from molecular studies to system-level investigations based on in vivo electrophysiological recordings and neurocomputational methods.

Key Features

  • Complete overview of hot topics and approaches to current PD research, from molecules, to brain circuits, to clinical and therapeutic applications
  • Leading authors review the state-of-the-art in their field of investigation, and provide their views and perspectives for future research
  • All chapters include comprehensive background information and are written in a clear form that is accessible also to the non-specialist


Neuroscientists, psychologists, neurologists


No. of pages:
© Elsevier 2010
20th August 2010
Hardcover ISBN:
eBook ISBN:

Ratings and Reviews

About the Serial Volume Editors

Anders Bjorklund

As a neuroanatomist and developmental neurobiologist, during the 1970s Björklund’s lab originated reliable methods for transplantation of embryonic tissues into brain that pioneered practical cell transplantation in the central nervous system, providing the basis for technologies that are now used by laboratories world-wide. In parallel, work in the field has progressed from basic anatomical and developmental studies in experimental animals, via applications for assessing cell replacement and repair using primary and stem cells in the damaged brain, and now underpinning the majority of methods in development for cell therapy in patients. His laboratory continues to analyse the fundamental neurobiology and principles of cell transplantation, regeneration and integration in the CNS, as well as originating the first trials of effective clinical cell transplantation (for Parkinson’s disease) in patients

Affiliations and Expertise

Lund University, Lund, Sweden

Angela Cenci-Nilsson

Angela Cenci-Nilsson

Angela Cenci Nilsson (author name M. A. Cenci) is Professor of Experimental Medical Research at Lund University (Sweden) where she heads the Basal Ganglia Pathophysiology Group). The group’s research activities address the pathophysiology and pharmacology of Parkinson’s disease (PD) and L-DOPA-induced dyskinesia using a multidisciplinary and translational approach. Current projects span a large variety of topics, including synaptic dysfunctions, dopamine receptor signaling, gliovascular-neuronal interactions, and neurorestorative treatments to enhance function and plasticity in the damaged nigrostriatal pathway. Angela has a combined clinical-basic science background, having graduated in Medicine and specialized in Neurology at the University of Verona (Italy) before obtaining a PhD degree in Neurobiology at Lund University under the supervision of Prof. Anders Björklund. In 2002 Angela received a tenured appointment as Associate Professor at Lund University, which was followed by an appointment as Full Professor in 2008. Angela has pioneered the development of symptomatic models of parkinsonism and L-DOPA-induced dyskinesia in rodents, and exploited these models to discover cellular mechanisms of disease and new therapeutic approaches. For these research achievements, she has received several awards (such as, the Erik K. Fernström Award for Young Promising Investigators, the Medal of Honours for Parkinson´s Research by the Swedish Parkinson’s Disease Foundation, and a recent membership in the Royal Academy for the Natural Sciences, Medicine and Technology in Lund). Angela currently serves on the scientific advisory boards and steering committees of several national and international research organizations, including the Swedish National Microscopy Infrastructure, The Swedish Parkinson’s Research Foundation, the Swedish Brain Foundation, the International Association for Parkinsonism and Related Disorders (IAPDR), and the International Basal Ganglia Society (IBAGS).

Affiliations and Expertise

Lund University, Sweden